Lotus Pharmaceutical (Taiwan) Analysis
| 1795 Stock | TWD 279.50 3.50 1.24% |
Lotus Pharmaceutical Co is overvalued with Real Value of 257.38 and Hype Value of 283.0. The main objective of Lotus Pharmaceutical stock analysis is to determine its intrinsic value, which is an estimate of what Lotus Pharmaceutical Co is worth, separate from its market price. There are two main types of Lotus Pharmaceutical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Lotus Pharmaceutical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Lotus Pharmaceutical's stock to identify patterns and trends that may indicate its future price movements.
The Lotus Pharmaceutical stock is traded in Taiwan on Taiwan Stock Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. Lotus Pharmaceutical is usually not traded on National Day of the Republic of China. Lotus Stock trading window is adjusted to Asia/Shanghai timezone.
Lotus |
Lotus Stock Analysis Notes
About 62.0% of the company shares are owned by insiders or employees . The book value of Lotus Pharmaceutical was presently reported as 51.3. The company recorded earning per share (EPS) of 11.86. Lotus Pharmaceutical last dividend was issued on the 4th of August 2022. The entity had 1060:1000 split on the 8th of September 2010. Lotus Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells medicines in Taiwan, Korea, the United States, and internationally. Lotus Pharmaceutical Co., Ltd. is a subsidiary of Alvogen Emerging Markets Holdings Limited. LOTUS PHARMACEUTICAL operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange. For more info on Lotus Pharmaceutical Co please contact the company at 886 2 2700 5908 or go to https://www.lotuspharm.com.tw.Lotus Pharmaceutical Investment Alerts
| Lotus Pharmaceutical generated a negative expected return over the last 90 days | |
| About 62.0% of the company shares are owned by insiders or employees |
Lotus Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 70.1 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lotus Pharmaceutical's market, we take the total number of its shares issued and multiply it by Lotus Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Lotus Profitablity
Lotus Pharmaceutical's profitability indicators refer to fundamental financial ratios that showcase Lotus Pharmaceutical's ability to generate income relative to its revenue or operating costs. If, let's say, Lotus Pharmaceutical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Lotus Pharmaceutical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Lotus Pharmaceutical's profitability requires more research than a typical breakdown of Lotus Pharmaceutical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.22 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.31 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.31. Technical Drivers
As of the 28th of November, Lotus Pharmaceutical secures the Mean Deviation of 1.41, risk adjusted performance of 0.0166, and Downside Deviation of 1.61. Lotus Pharmaceutical Co technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Lotus Pharmaceutical standard deviation, information ratio, treynor ratio, as well as the relationship between the variance and jensen alpha to decide if Lotus Pharmaceutical Co is priced some-what accurately, providing market reflects its recent price of 279.5 per share.Lotus Pharmaceutical Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Lotus Pharmaceutical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Lotus Pharmaceutical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Lotus Pharmaceutical Outstanding Bonds
Lotus Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Lotus Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Lotus bonds can be classified according to their maturity, which is the date when Lotus Pharmaceutical Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Lotus Pharmaceutical Predictive Daily Indicators
Lotus Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Lotus Pharmaceutical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 50446.83 | |||
| Daily Balance Of Power | (0.41) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 283.25 | |||
| Day Typical Price | 282.0 | |||
| Price Action Indicator | (5.50) | |||
| Period Momentum Indicator | (3.50) | |||
| Relative Strength Index | 62.22 |
Lotus Pharmaceutical Forecast Models
Lotus Pharmaceutical's time-series forecasting models are one of many Lotus Pharmaceutical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Lotus Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Lotus Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Lotus Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Lotus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Lotus Pharmaceutical. By using and applying Lotus Stock analysis, traders can create a robust methodology for identifying Lotus entry and exit points for their positions.
Lotus Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells medicines in Taiwan, Korea, the United States, and internationally. Lotus Pharmaceutical Co., Ltd. is a subsidiary of Alvogen Emerging Markets Holdings Limited. LOTUS PHARMACEUTICAL operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Lotus Pharmaceutical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Additional Tools for Lotus Stock Analysis
When running Lotus Pharmaceutical's price analysis, check to measure Lotus Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceutical is operating at the current time. Most of Lotus Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceutical's price. Additionally, you may evaluate how the addition of Lotus Pharmaceutical to your portfolios can decrease your overall portfolio volatility.